论文部分内容阅读
目的总结分析甲基多巴联合拉贝洛尔在重度子痫前期综合征治疗中的应用效果。方法选择2011年1月至2015年10月72例重度子痫前期综合征患者为研究对象,随机分为观察组和对照组,每组36例,两组均给予硫酸镁等常规治疗和常规护理,对照组患者给予甲基多巴治疗,观察组患者给予甲基多巴联合拉贝洛尔治疗。比较两组疗效及血压变化、妊娠延长时间以及胎儿宫内窘迫、产后出血、新生儿窒息等不良反应发生情况。结果观察组治疗总有效率(88.89%)明显高于对照组(69.44%),差异有统计学意义(P<0.05);观察组血压下降幅度明显大于对照组(P<0.01),两组不良事件发生率比较差异未见统计学意义(P>0.05)。结论甲基多巴联合拉贝洛尔对重度子痫前期综合征治疗有效,能有效降低血压、延长妊娠时间,降低不良反应发生率,值得推广使用。
Objective To summarize and analyze the application of methyldopa combined with labetalol in the treatment of severe preeclampsia syndrome. Methods Seventy-two patients with severe preeclampsia from January 2011 to October 2015 were selected and randomly divided into observation group and control group, with 36 cases in each group. Both groups were given conventional therapy and routine nursing such as magnesium sulfate , Patients in the control group were treated with methyldopa, and patients in the observation group were treated with methyldopa and labetalol. The incidence of adverse reactions such as changes of blood pressure, prolongation of pregnancy, fetal distress, postpartum hemorrhage and neonatal asphyxia were compared between the two groups. Results The total effective rate (88.89%) in observation group was significantly higher than that in control group (69.44%), the difference was statistically significant (P <0.05); the decrease of blood pressure in observation group was significantly greater than that in control group (P <0.01) The incidence of events was not statistically significant (P> 0.05). Conclusion Methyl-dopa combined with labetalol is effective in treating severe preeclampsia syndrome, which can effectively lower blood pressure, prolong the time of pregnancy and reduce the incidence of adverse reactions, which is worth popularizing.